MedTrace Logo

A Study to Compare Genetic Variations of IGF-I and IGF-II

NCT01329523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2011-10-06

No results posted yet for this study

Summary

The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of the AD patients and individuals without AD matched by age to the AD patients.

Conditions

Sponsors & Collaborators

  • Avera McKennan Hospital & University Health Center

    lead OTHER

Principal Investigators

  • Umesh Chakunta, MD · Avera McKennan Hospital & University Health Center

Eligibility

Min Age
50 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01329523 on ClinicalTrials.gov